Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: CAL stock price vs ACAD: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACAD's multiple
Needs ACAD P/S.
Implied fair value · at CAL's multiple
Needs CAL P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CAL FY 2026 (ended Jan 31, 2026) · ACAD FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
CALERES, INC · implied price per share
Bear
-$16.29
Base
-$19.16
Bull
-$22.04
ACADIA PHARMACEUTICALS INC. · implied price per share
Bear
$5.79
Base
$6.81
Bull
$7.83
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.33x
0.00x
Net debt / EBITDA
Leverage against operating earnings
1.85x
-1.51x
Cash and equivalents
Liquid reserves on the balance sheet
$29.77M
$227.76M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Crocs, Inc.
CAL vs CROX
DECKERS OUTDOOR CORP
CAL vs DECK
SKECHERS USA INC
CAL vs SKX
STEVEN MADDEN, LTD.
CAL vs SHOO
GENESCO INC
CAL vs GCO
SUPERNUS PHARMACEUTICALS, INC.
CAL vs SUPN
Sage Therapeutics, Inc.
CAL vs SAGE
Jazz Pharmaceuticals plc
CAL vs JAZZ
Alkermes plc.
CAL vs ALKS
Harmony Biosciences Holdings, Inc.
CAL vs HRMY
Krystal Biotech, Inc.
CAL vs KRYS
$198.85M
$32.00K
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
